Zhen Jin

496 total citations
19 papers, 342 citations indexed

About

Zhen Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhen Jin has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Zhen Jin's work include CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Cell Function and Interaction (4 papers). Zhen Jin is often cited by papers focused on CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Cell Function and Interaction (4 papers). Zhen Jin collaborates with scholars based in China, United States and Thailand. Zhen Jin's co-authors include Junmin Li, Yingxiao Wang, Yijia Pan, Aaron Jacobson, Robert H. Bussell, Ziliang Huang, Yahan Liu, M. M. Allen, Praopim Limsakul and Shu Chien and has published in prestigious journals such as Blood, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Zhen Jin

17 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen Jin China 8 177 134 117 65 59 19 342
Anat Globerson Levin Israel 11 226 1.3× 104 0.8× 183 1.6× 135 2.1× 45 0.8× 20 370
Martina Schüßler‐Lenz Germany 6 349 2.0× 103 0.8× 180 1.5× 127 2.0× 119 2.0× 9 445
Morgane Boulch France 7 237 1.3× 76 0.6× 128 1.1× 216 3.3× 59 1.0× 8 408
Deanna Langfitt United States 8 246 1.4× 75 0.6× 117 1.0× 117 1.8× 71 1.2× 15 315
Reyisa Bughda United Kingdom 6 243 1.4× 76 0.6× 114 1.0× 87 1.3× 39 0.7× 9 313
Sophia Stock Germany 9 337 1.9× 110 0.8× 146 1.2× 121 1.9× 97 1.6× 16 383
Ashwini Balakrishnan United States 5 347 2.0× 116 0.9× 202 1.7× 114 1.8× 91 1.5× 7 448
Sanaz Taromi Germany 9 305 1.7× 77 0.6× 156 1.3× 139 2.1× 62 1.1× 13 422
Tianning Gu China 9 166 0.9× 46 0.3× 119 1.0× 66 1.0× 47 0.8× 14 266
Trisha R. Berger United States 9 373 2.1× 133 1.0× 147 1.3× 175 2.7× 102 1.7× 20 469

Countries citing papers authored by Zhen Jin

Since Specialization
Citations

This map shows the geographic impact of Zhen Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Jin more than expected).

Fields of papers citing papers by Zhen Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Jin. The network helps show where Zhen Jin may publish in the future.

Co-authorship network of co-authors of Zhen Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Jin. A scholar is included among the top collaborators of Zhen Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Jin. Zhen Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Min, Zhen Jin, Yang Li, et al.. (2025). Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol. Future Oncology. 21(8). 953–958. 2 indexed citations
2.
Zhou, Zhengrong, et al.. (2025). m6A methylation modification of RNA plays a significant role in the occurrence and development of colorectal cancer. International Journal of Biological Macromolecules. 315(Pt 2). 144666–144666.
3.
4.
Jin, Zhen, Zhen Yuan, Zhiyuan Yu, et al.. (2024). YAP Promotes Chemoresistance to 5-FU in Colorectal Cancer Through mTOR/GLUT3 Axis. Journal of Cancer. 15(20). 6784–6797. 5 indexed citations
5.
Jin, Peng, Xiaoyang Li, Jie Shen, et al.. (2024). A CD8+ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia. Frontiers in Immunology. 15. 1408109–1408109. 1 indexed citations
6.
Jin, Peng, Jie Shen, Ming Zhao, et al.. (2024). Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy. Cancer Letters. 611. 217427–217427. 3 indexed citations
7.
Jin, Zhen, Kai Qing, Dan Li, et al.. (2023). Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma. Cellular Oncology. 46(4). 1143–1157. 11 indexed citations
8.
9.
Wu, Yiqian, Yahan Liu, Ziliang Huang, et al.. (2021). Control of the activity of CAR-T cells within tumours via focused ultrasound. Nature Biomedical Engineering. 5(11). 1336–1347. 161 indexed citations
10.
Li, Ran, Peng Jin, Wenfang Wang, et al.. (2021). Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes. Frontiers in Immunology. 12. 639634–639634. 12 indexed citations
11.
Qing, Kai, Zhen Jin, Wenfang Wang, et al.. (2021). Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Chemotherapy. 67(1). 12–23. 4 indexed citations
12.
13.
Jin, Zhen, Kai Qing, Xiaoyang Li, et al.. (2018). The severe cytokine release syndrome in phase I trials of CD19-CAR-T cell therapy: a systematic review. Annals of Hematology. 97(8). 1327–1335. 42 indexed citations
14.
Li, Dan, Zhen Jin, You Zhai, et al.. (2018). TanCAR T cells targeting CD19 and CD133 efficiently eliminate MLL leukemic cells. Leukemia. 32(9). 2012–2016. 39 indexed citations
15.
Jin, Zhen, Kai Qing, Zhao Liu, et al.. (2016). Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma. Journal of Experimental & Clinical Cancer Research. 35(1). 52–52. 17 indexed citations
16.
17.
18.
Jin, Zhen, et al.. (2014). RNA-Seq analysis identifies aberrant RNA splicing of TRIP12 in acute myeloid leukemia patients at remission. Tumor Biology. 35(10). 9585–9590. 5 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anat Globerson Levin Breakdown of academic impact, for papers by Martina Schüßler‐Lenz Breakdown of academic impact, for papers by Morgane Boulch Breakdown of academic impact, for papers by Deanna Langfitt Breakdown of academic impact, for papers by Reyisa Bughda Breakdown of academic impact, for papers by Sophia Stock Breakdown of academic impact, for papers by Ashwini Balakrishnan Breakdown of academic impact, for papers by Sanaz Taromi Breakdown of academic impact, for papers by Tianning Gu Breakdown of academic impact, for papers by Trisha R. Berger
Rankless by CCL
2026